REGELTEC has developed the Hydrafil System to eliviate spinal pain due to degeneration and will probably gey FDA approval. Huge market
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
A product which reduces back pain will be a HUGE winner. 16 million adults in the USA suffer from chronic back pain. ReGelTec is currently funded by only 3 parties to the tune of about $6M. No news on the website of a future IPO. If the do go public I’ll be first in line.